(Q57917633)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15937505%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

title

Reduced-intensity hematopoietic stem-cell transplantation for malignant lymphoma: a retrospective survey of 112 adult patients in Japan (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15937505%20AND%20SRC:MED&resulttype=core&format=json

stem cell transplantation

12 January 2020

main subject

1 reference

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15937505%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Kengo Takeuchi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15937505%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

author name string

Kusumi E

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15937505%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Kami M

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15937505%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Kanda Y

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15937505%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Murashige N

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15937505%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Kishi Y

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15937505%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Tanimoto TE

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15937505%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Mori T

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15937505%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Muta K

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15937505%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Tamaki T

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15937505%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Tanaka Y

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15937505%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Ogawa H

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15937505%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Yamane T

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15937505%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Taniguchi S

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15937505%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Takaue Y

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15937505%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

language of work or name

English

0 references

publication date

1 August 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15937505%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

12 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15937505%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

volume

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15937505%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15937505%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

page(s)

205-213

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15937505%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1705027

12 January 2020

exact match

0 references

cites work

Autologous versus allogeneic bone marrow transplantation for non-Hodgkin's lymphoma: a case-controlled analysis of the European Bone Marrow Transplant Group Registry data

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705027

Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705027

A nationwide survey of deep fungal infections and fungal prophylaxis after hematopoietic stem cell transplantation in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705027

Second EBMT Workshop on reduced intensity allogeneic hemopoietic stem cell transplants (RI-HSCT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705027

Third EBMT/AMGEN Workshop on reduced-intensity conditioning allogeneic haemopoietic stem cell transplants (RIC-HSCT), and panel consensus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705027

The new World Health Organization classification of lymphomas: the past, the present and the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705027

Estimation of failure probabilities in the presence of competing risks: new representations of old estimators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705027

Toxicity and response criteria of the Eastern Cooperative Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705027

Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705027

Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705027

Chemoresistant or aggressive lymphoma predicts for a poor outcome following reduced-intensity allogeneic progenitor cell transplantation: an analysis from the Lymphoma Working Party of the European Group for Blood and Bone Marrow Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705027

Clinical impact of graft-versus-host disease against leukemias not in remission at the time of allogeneic hematopoietic stem cell transplantation from related donors. The Japan Society for Hematopoietic Cell Transplantation Working Party.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705027

Risk for cytomegalovirus infection following reduced intensity allogeneic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705027

Development of early neutropenic fever, with or without bacterial infection, is still a significant complication after reduced-intensity stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705027

Allogeneic bone marrow transplantation for poor-prognosis lymphoma: response, toxicity and survival depend on disease histology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705027

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705027

Reduced-intensity preparative regimen and allogeneic stem cell transplantation for advanced solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705027

Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705027

Reduced-intensity stem cell transplantation from an HLA-identical sibling donor in patients with myeloid malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705027

Rituximab as adjuvant to high-dose therapy and autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705027

Complete remission in a patient with recurrent acute myeloid leukemia induced by vaccination with WT1 peptide in the absence of hematological or renal toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705027

Allogeneic bone marrow transplantation with T-cell-depleted marrow grafts for patients with poor-risk relapsed low-grade non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705027

7 January 2021

Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705027

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705027

7 January 2021

Allogeneic bone marrow transplantation in aggressive non-Hodgkin's lymphoma (excluding Burkitt and lymphoblastic lymphoma): a series of 73 patients from the SFGM database

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705027

7 January 2021

Syngeneic hematopoietic stem-cell transplantation for non-Hodgkin's lymphoma: a comparison with allogeneic and autologous transplantation--The Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705027

7 January 2021

Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705027

7 January 2021

Incidence of invasive aspergillosis after allogeneic hematopoietic stem cell transplantation with a reduced-intensity regimen compared with transplantation with a conventional regimen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705027

7 January 2021

Antithymocyte globulin affects the occurrence of acute and chronic graft-versus-host disease after a reduced-intensity conditioning regimen by modulating mixed chimerism induction and immune reconstitution

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705027

7 January 2021

Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705027

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1705027

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15937505%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

1 reference